Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) Homo sapiens (Human) Polyclonal antibody

CDKN2; p33(CDK2); Cell division protein kinase 2; p33 protein kinase

Add to Cart Distributors
Overview
Properties
  • SourcePolyclonal antibody preparation, Host Rabbit
  • Ig Type IgG, Potency n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Immunogen RPB889Hu02-Recombinant Cyclin Dependent Kinase 2 (CDK2)
  • Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
  • TraitsLiquid, Concentration 500µg/mL
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) Packages (Simulation)
  • Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) Packages (Simulation)
  • Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) IHC Images
  • Polyclonal Antibody to Cyclin Dependent Kinase 2 (CDK2) AF488 staining on IF;
    Sample: HepG2 cell
    Primary Ab: 20µg/ml Rabbit Anti-Human CDK2 Antibody
    Second Ab: 2μg/ml AF488-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb11)
  • PAB889Hu02.jpg Figure. Western Blot; Sample: Recombinant CDK2, Human.
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a rabbit polyclonal antibody raised against CDK2. It has been selected for its ability to recognize CDK2 in immunohistochemical staining and western blotting.

Usage

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • The nanoparticulate Quillaja saponin KGI exerts anti-proliferative effects by down-regulation of cell cycle molecules in U937 and HL-60 human leukemia cellsPubmed: 24138332
  • Construction of some cytotoxic agents with aurone and furoaurone scaffoldspubmed:29235893
  • Synthesis of Novel Heterocyclic Compounds Containing Benzothiophene of Expected Anticancer Activity.:

Recommend products